This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
Kailera Therapeutics Inc KLRA
$21.17
▲ +0.43%
(+$0.09)
Open
$21.20
Prev Close
$21.08
Day Range
$20.95 – $21.72
52W Range
$19.01 – $28.23
Market Cap
$2.74B
Beta
-4.77
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2026-04-17 |
| Website | kailera.com ↗ |
| Phone | 15084409475 |
Kailera Therapeutics Inc is a publicly traded company under the ticker symbol KLRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📰 Latest News for KLRA
Hengrui Pharma, Kailera Therapeutics To Present Two Abstracts At 86th Scientific Sessions Of The American Diabetes Association
Leerink Partners Initiates Coverage On Kailera Therapeutics with Outperform Rating, Announces Price Target of $36
Jefferies Initiates Coverage On Kailera Therapeutics with Buy Rating, Announces Price Target of $48
Evercore ISI Group Initiates Coverage On Kailera Therapeutics with Outperform Rating
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
JP Morgan Initiates Coverage On Kailera Therapeutics with Overweight Rating, Announces Price Target of $30